上海润达医疗科技股份有限公司

Fundraising and Usage Overview - As of December 31, 2024, the company raised a total of RMB 540,100,000 through convertible bonds, with a net amount of RMB 537,907,547 after deducting issuance costs [1] - The actual investment amount for the "Comprehensive Service Expansion Project" is RMB 66,085.43 million, while the actual raised funds available for investment are RMB 53,790.75 million, indicating a shortfall that the company plans to cover through self-financing [2] Pre-Investment and Replacement - Prior to the arrival of the raised funds, the company invested RMB 93,618,000 from its own resources into the project to ensure smooth implementation [4] - The board approved the use of raised funds to replace the pre-invested self-financing amount of RMB 93,618,000 [4] Temporary Use of Idle Funds - As of December 31, 2024, the company temporarily used RMB 18,000,000 of idle raised funds to supplement working capital, with a maximum limit of RMB 25,000,000 approved by the board [5][6] - The company has consistently returned the used funds to the designated account within the stipulated timeframes [5][6][6] Project Delays - The "Comprehensive Service Expansion Project" has been postponed multiple times, with the latest extension approved to May 30, 2026, due to actual operational needs [9][10] Financial Performance - For the year 2024, the company generated sales revenue of RMB 34,547,960 and a net profit of RMB 207,030 from the raised funds, resulting in a sales profit margin of 0.60% [16] - The project is expected to achieve an average annual sales revenue of RMB 90,611,780 and an average annual net profit of RMB 7,781,910 upon reaching full capacity [16] Profit Distribution Plan - The company plans to distribute a cash dividend of RMB 0.30 per share, totaling RMB 18,109,208.37, based on a total share capital of 603,640,279 shares as of December 31, 2024 [20] - The cash dividend payout ratio for the year is 32.76% [20] Guarantee and Risk Management - The company plans to provide guarantees for a total of RMB 422,100,000 in credit limits for its subsidiaries in 2025, with an actual guarantee balance of RMB 314,777,510 as of the announcement date [28] - The company has ensured that the guarantees are backed by equal guarantees from other shareholders of the subsidiaries [28]